C4X Discovery Holdings plc (C4XD) Ordinary Shares 1p

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
C4X Discovery appoints Cathy Tralau-Stewart as new science chief
21 December 2021 12:57
(Sharecast News) - Drug discovery company C4X announced the appointment of Catherine Tralau-Stewart as its new chief scientific officer on Tuesday, effective from 4 January.
-
C4X Discovery signs exclusive licensing deal with Sanofi
12 April 2021 08:41
(Sharecast News) - C4X Discovery has signed an exclusive worldwide licensing agreement with Sanofi worth up to €414m (£357.84m), it announced on Monday, for its oral preclinical IL-17A inhibitor programme.
-
C4X Discovery CEO to be interim chair of UK Vaccine Taskforce
8 December 2020 12:26
(Sharecast News) - Drug discovery company C4X Discovery confirmed on Tuesday that its chief executive officer Clive Dix has stepped into the role of interim chair of the UK Vaccine Taskforce.
-
C4X losses widen as its revenue drops to nil
7 January 2020 09:59
(Sharecast News) - Drug discovery company C4X Discovery Holdings announced a fall in revenue to nil in its full-year results on Tuesday, from £7.06m in 2018, which the board said as driven entirely by the...
-
C4X makes solid progress across portfolio of programmes
1 October 2019 10:15
(Sharecast News) - Drug discovery company C4X Discovery Holdings announced progress across a number of key programmes in line with its strategy on Tuesday, reporting that it was continuing to progress its...
-
C4X upbeat as its molecule progresses with Indivior
27 September 2019 15:39
(Sharecast News) - Drug discovery company C4X Discovery Holdings noted an announcement on Friday that the National Institutes of Health (NIH) in the United States has granted Indivior's application...
Company announcements Announcements
-
AIM Rule 17 Schedule 2(g) Update
28 June 2022 17:46
C4X Discovery Holdings
-
Half Year Results
28 April 2022 07:00
C4X Discovery Holdings
-
Notice of Results
19 April 2022 07:00
C4X Discovery Holdings
-
Exercise of Options, Issue of Equity and TVR
28 February 2022 17:30
C4X Discovery Holdings
-
Grant of Options and Directors Dealing
3 February 2022 07:00
C4X Discovery Holdings
-
Block listing Return
1 February 2022 07:00
C4X Discovery Holdings
-
Bhavna Hunjan Appointed as Chief Business Officer
1 February 2022 07:00
C4X Discovery Holdings
-
Holding(s) in Company
24 January 2022 16:09
C4X Discovery Holdings
-
Result of AGM
18 January 2022 15:07
C4X Discovery Holdings
-
Holdings in Company
14 January 2022 15:20
C4X Discovery Holdings
-
Appointment of Dr Cathy Tralau-Stewart as CSO
21 December 2021 07:00
C4X Discovery Holdings
-
Annual Report and Notice of AGM
15 December 2021 07:00
C4X Discovery Holdings
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2022. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.